Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

HEPA

Hepion Pharmaceuticals (HEPA)

Hepion Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HEPA
DateTimeSourceHeadlineSymbolCompany
06/12/20204:48PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HEPAHepion Pharmaceuticals Inc
06/10/20205:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
02/07/20204:47PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
02/05/20203:26PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:HEPAHepion Pharmaceuticals Inc
01/28/20204:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
01/09/20206:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
01/06/20204:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
12/11/20191:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
12/04/20196:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
12/03/20194:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
11/21/20196:03AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HEPAHepion Pharmaceuticals Inc
11/14/20195:19PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HEPAHepion Pharmaceuticals Inc
09/04/20198:30AMGlobeNewswire Inc.Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment ConferenceNASDAQ:HEPAHepion Pharmaceuticals Inc
09/03/20194:30PMGlobeNewswire Inc.Hepion Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementsNASDAQ:HEPAHepion Pharmaceuticals Inc
08/14/20198:30AMGlobeNewswire Inc.Hepion Pharmaceuticals Announces Dosing of First HBV Patient in 28-Day Study of CRV431NASDAQ:HEPAHepion Pharmaceuticals Inc
08/07/20191:00PMGlobeNewswire Inc.Hepion Pharmaceuticals Welcomes Dr. Stephen Harrison to its Scientific Advisory BoardNASDAQ:HEPAHepion Pharmaceuticals Inc
07/31/20199:20AMGlobeNewswire Inc.Hepion Pharmaceuticals Announces Research Partnership with Applied Pharmaceutical Innovation, Faculty of Pharmacy & Pharmaceu...NASDAQ:HEPAHepion Pharmaceuticals Inc
07/29/20194:15PMGlobeNewswire Inc.Hepion Pharmaceuticals Receives FDA Authorization to Proceed with IND Opening Study of CRV431 for NASHNASDAQ:HEPAHepion Pharmaceuticals Inc
07/22/20192:00PMGlobeNewswire Inc.ContraVir Pharmaceuticals Announces Name Change to Hepion Pharmaceuticals, Inc.; Trading Symbol Change to “HEPA”NASDAQ:HEPAHepion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:HEPA